logo
Rock Island proposes compromise for Milan Bottoms development

Rock Island proposes compromise for Milan Bottoms development

Yahoo22-03-2025

Mayor Mike Thoms held a news conference Friday about a controversial proposed development near the Milan Bottoms wetlands area.
The city has created a task force to help maintain conservation for the site. Meanwhile, the city wants to expand an already-existing TIF – Tax Increment Financing – district to include more property where the dispensary and truck stop are proposed.
'The mayor was pretty explicit in saying that we're going to proceed with this development, but at the same time, also proceed with trying to create a permanent conservation easement on the wetland behind the site,' said Jon Duyvejonck, a member of the Sierra Club Eagle View Group. 'So we kind of agree to disagree. So there are still environmental steps to be taken to approve this project.'
The Rock Island City Council will vote to approve the easement on Monday. One part of the compromise would be maintain a tree line between the development and the wetlands to help block some of the light and noise.
'We must strive to balance the city's need for economic development with the environment, environmental conservation, which I believe can be hand-in-hand,' said Thoms. 'The city is committed to economic development while protecting our natural resources.'
Thoms also announced that a groundbreaking for the project is planned for next month.
'I think it's kind of premature to do that, but then again, a lot of the groundbreakings I've been a part of are just kind of a formal thing,' said Duyvejonck.
Duyvejonck says some activists plan to attend Monday's city council meeting to discuss holding off on plans for the TIF to make time for more environmental surveys.
What is a TIF district?
A TIF is a tool municipalities can use to spur economic development in certain areas by designating them as eligible to use an increase in property tax revenue generated by new development within those areas to fund projects and improvements.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Luminar Technologies, Inc. (LAZR) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Luminar Technologies, Inc. (LAZR) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Yahoo

time30 minutes ago

  • Yahoo

Luminar Technologies, Inc. (LAZR) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Luminar Technologies, Inc. (LAZR) closed the latest trading day at $3.27, indicating a -5.49% change from the previous session's end. The stock's change was less than the S&P 500's daily loss of 0.27%. Shares of the company witnessed a loss of 23.62% over the previous month, trailing the performance of the Auto-Tires-Trucks sector with its gain of 5.86%, and the S&P 500's gain of 6.9%. Analysts and investors alike will be keeping a close eye on the performance of Luminar Technologies, Inc. in its upcoming earnings disclosure. On that day, Luminar Technologies, Inc. is projected to report earnings of -$1.19 per share, which would represent year-over-year growth of 55.93%. Meanwhile, our latest consensus estimate is calling for revenue of $16.72 million, up 1.64% from the prior-year quarter. For the full year, the Zacks Consensus Estimates are projecting earnings of -$4.29 per share and revenue of $86.64 million, which would represent changes of +53.57% and +14.91%, respectively, from the prior year. Investors should also pay attention to any latest changes in analyst estimates for Luminar Technologies, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 21.36% higher within the past month. Luminar Technologies, Inc. is currently sporting a Zacks Rank of #2 (Buy). The Automotive - Original Equipment industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 131, which puts it in the bottom 47% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Luminar Technologies, Inc. (LAZR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Yahoo

timean hour ago

  • Yahoo

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, which showed a mean weight loss of up to 8.4% at Day 36 after subtracting the placebo. A laboratory technician researching a sample of cells in a biotechnology laboratory. The candidate supported monthly dosing with the longest half-life of any known amylin analog, 19 days. MET-233i had no safety indications and was well tolerated. The trial included 80 overweight or obese participants, with individual cases resulting in weight loss of up to 10.2%. MET-233i displayed high tolerability and dose-linear pharmacokinetics when tested in both single and multiple ascending dose formats. The majority of adverse gastrointestinal events occurred in the first week and were mild and dose-dependent. According to preliminary findings, it might make it practical to use its fully-biased GLP-1 RA candidate, MET-097i, in the first monthly GLP-1 + amylin combination therapy. Topline results from combination trials and an ongoing monotherapy study with MET-097i are anticipated in late 2025. Metsera, Inc. (NASDAQ:MTSR)'s HALO™ peptide stabilization platform supports the program. Metsera, Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical business focused on developing new treatments for obesity and metabolic diseases. It is one of the stocks with the biggest upside. While we acknowledge the potential of MTSR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mitchell, Worthing mayors opposed to nearby prison sites
Mitchell, Worthing mayors opposed to nearby prison sites

Yahoo

timean hour ago

  • Yahoo

Mitchell, Worthing mayors opposed to nearby prison sites

SIOUX FALLS, S.D. (KELO) — Project Prison Reset's task force members have endorsed construction at existing Department of Corrections sites or proposed sites in the Mitchell or Worthing areas. However, the mayors of those two towns are not in favor of the locations near their communities. Motorcycle event an alternative to street racing 'Personally, I do not support,' Worthing Mayor Crystal Jacobson said Wednesday. 'It will be financially impacting on our town in a way that I don't know if we can recover from it.' 'I don't support it just because the people don't appear to support it around our town,' Mitchell Mayor Jordan Hanson said Wednesday. 'So, I hate to be the guy that does the opposite of what the people elected me to do … I don't know better than the people I'm elected to represent, so that's what I'm doing.' Hanson says his thinking has evolved. 'When I first heard about it, I was really excited about it, the promise of jobs and economic expansion and just the betterment it could bring to our community was my initial reaction, and that's why I was like, this sounds great,' Hanson said. Now, he has a clear message for anyone considering the sites. 'If they want or the task force or the state wants it to come to Mitchell, they better really step up their game and start getting people information in our community if they really want to get people on board,' Hanson said. Jacobson is focused on the financial considerations. 'We do not have enough structure for additional housing if inmates' families or workers want to move down there,' Jacobson said. 'We just built a new sewer system that'll accommodate 130 houses, and after that we would have to go the next step up in the sewer. We don't have the money for it. We're on a very small budget.' The task force's next meeting is scheduled for July 8. Eventually, a special session of the state legislature is planned where lawmakers can learn about the group's recommendations. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store